These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34121681)

  • 21. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
    Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectal complication probability from composite volumes derived from daily cone beam computed tomography in prostate cancer radiotherapy.
    Prabhakar R; Oates R; Daryl J; Chang J; Geso M; Cramb J
    J Cancer Res Ther; 2016; 12(1):374-8. PubMed ID: 27072266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN; Fütterer JJ; Heijmink SW; van der Vight LP; Hoffmann AL; van Kollenburg P; Huisman HJ; Scheenen TW; Witjes JA; Leer JW; Barentsz JO; Visser AG
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):291-303. PubMed ID: 16618584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?
    Teh BS; McGary JE; Dong L; Mai WY; Carpenter LS; Lu HH; Chiu JK; Woo SY; Grant WH; Butler EB
    Cancer J; 2002; 8(6):476-83. PubMed ID: 12500857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of rectal displacement devices during prostate external-beam radiation therapy: A review.
    Sanei M; Ghaffari H; Ardekani MA; Mahdavi SR; Mofid B; Abdollahi H; Rostami A
    J Cancer Res Ther; 2021; 17(2):303-310. PubMed ID: 34121672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
    Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
    Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy.
    Chao M; Ho H; Chan Y; Tan A; Pham T; Bolton D; Troy A; Temelcos C; Sengupta S; McMillan K; Cham CW; Liu M; Ding W; Subramanian B; Wasiak J; Lim Joon D; Spencer S; Lawrentschuk N
    BJU Int; 2018 Sep; 122(3):427-433. PubMed ID: 29520983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
    Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interfractional Rectal Displacement Requiring Repeated Precaution Did Not Correlate to Biochemical Control and Rectal Toxicity in Patients with Prostate Cancer Treated with Image-guided Intensity-modulated Radiation Therapy.
    Iwama K; Yamazaki H; Shimizu D; Suzuki G; Nakamura S; Sasaki N; Takeneka T; Okabe H; Nishikawa T; Yoshida K
    Anticancer Res; 2017 Oct; 37(10):5755-5760. PubMed ID: 28982897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
    O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
    Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
    Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
    De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
    Pinkawa M; Corral NE; Caffaro M; Piroth MD; Holy R; Djukic V; Otto G; Schoth F; Eble MJ
    Radiother Oncol; 2011 Sep; 100(3):436-41. PubMed ID: 21963289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
    Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.
    Inokuchi H; Mizowaki T; Norihisa Y; Takayama K; Ikeda I; Nakamura K; Nakamura M; Hiraoka M
    Int J Clin Oncol; 2016 Feb; 21(1):156-61. PubMed ID: 26164689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
    Boehmer D; Kuczer D; Badakhshi H; Stiefel S; Kuschke W; Wernecke KD; Budach V
    Strahlenther Onkol; 2006 May; 182(5):277-82. PubMed ID: 16673061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer.
    Vargas C; Mahajan C; Fryer A; Indelicato D; Henderson RH; McKenzie C; Horne D; Chellini A; Lawlor P; Li Z; Oliver K; Keole S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1110-6. PubMed ID: 17967305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
    Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.
    Bohrer M; Schröder P; Welzel G; Wertz H; Lohr F; Wenz F; Mai SK
    Strahlenther Onkol; 2008 Dec; 184(12):674-8. PubMed ID: 19107349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.